CTOs on the Move

Agility Health

www.agilityhealth.com

 
Agility Health is a leading healthcare provider devoted to the rehabilitation of our patients' physical injuries and conditions. Established in 1968, Agility Health delivers personalized care through over one million therapy visits annually at more than 155 service sites in 20 states nationwide. Our team is dedicated to providing exceptional value to the patients, clients and partners we serve. Through our innovative clinical services, proven practice management systems and flexible partnerships, we help achieve optimal performance in a variety of settings, including outpatient clinics, hospitals, long-term care facilities and employer work sites. Agility Health is one of the top 10 rehabilitation services ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Onward Healthcare

Onward Healthcare is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Houchin Community Blood Bank

Houchin Community Blood Bank is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Barber Optics Inc

Barber Optics Inc is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AirWare Labs

A globally patented adhesive-free nasal insert. Take advantage of your nasal system for optimal health. Drug-free, latex-free. All natural, instant relief.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.